BDNF and ovarian carcinoma: Meanwhile, Heitz et al. claimed that selective β-blockers intake did not influence the prognosis for ovarian cancer patients.129 Regarding neurotrophic factors, NGF, BDNF, and their TrK receptors are the current research hotspots.